A Tax-Cutting Move That Pfizer Can Hardly Resist
Give Pfizer, the giant drug maker, points for boldness and persistence: The company has bravely put “tax inversions” back in the headlines. [ by Jeff Sommer | November 14, 2015 | NY Times ] Pfizer, which already holds roughly $140 billion overseas and is quite skillful at minimizing its taxes, is considering a deal…